Position in TLRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$39,835
New position
Shares Held
6,157
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $12,077,917 across 41 Drug Manufacturers - Specialty & Generic names. TLRY ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
25,997 | $3,073,100 | |
| 2 | LQDA |
Liquidia Corp
|
64,935 | $2,450,646 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
64,287 | $1,936,323 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
47,846 | $1,144,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
52,964 | $980,891 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,342 | $795,777 | |
| 7 | HLN |
Haleon plc
|
31,406 | $314,370 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
3,785 | $224,336 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,835 | 6,157 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||